Weight loss and diabetes jabs linked to potentially fatal side effect
Weight loss and diabetes jabs taken by more than a million people in the UK have been linked to a potential serious side effect, with some deaths, according to data from the UK medicines regulator.
New figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show the group of drugs that includes Mounjaro, Wegovy, and Ozempic may be associated with inflammation of the pancreas.
According to the MHRA, there have been 181 reported cases of acute or chronic pancreatitis linked to Mounjaro, with five deaths.
Wegovy and Ozempic have been linked with 113 reports of pancreatitis and one death.
Other, less widely used versions of so-called GLP-1 drugs have also been linked to cases and deaths.
There is no evidence that the drugs directly caused the deaths. And the evidence isn't strong enough for the MHRA to restrict access.
1:31
That's because pancreatitis also occurs in people who aren't taking the GLP-1 drugs, with about 560 cases for every one million people in the general population. Gallstones and alcohol are the biggest causes.
But the MHRA and Genomics England are launching a new study to see whether some people have genes that put them at higher risk of developing pancreatitis if they take GLP-1 drugs.
People reported through the MHRA's 'yellow card' alert system to have pancreatitis while using the jabs will be asked to provide a saliva sample and their genes tested.
Professor Matt Brown, chief scientific officer of Genomics England, said: "GLP-1 medicines like Ozempic and Wegovy have been making headlines, but like all medicines, there can be a risk of serious side effects.
"We believe there is real potential to minimise these, with many adverse reactions having a genetic cause.
"This next step in our partnership with the MHRA will generate data and evidence for safer and more effective treatment through more personalised approaches to prescription."
The main symptoms of pancreatitis are severe pain in the centre of the tummy area, fever and nausea. Acute cases are treated in hospital with fluids and oxygen, and generally make a recovery within a few days.
But there can be complications, and around 5% of acute cases are fatal.
With all medicines, there is a balance of risk and benefit.
For people with type 2 diabetes or obesity, there are clear benefits to using the jabs.
They lower blood sugar levels, lead to rapid weight loss and reduce deaths from cardiovascular disease by a fifth.
But for people who are a bit overweight and have sourced the jabs privately to lose a few pounds ahead of their summer holiday, the health benefits are far less clear.
This is a wake-up call for them.
These are powerful medications with effects not just on appetite, but on lots of body organs, including the brain.
And pancreatitis is just one of many possible side effects.
Lilly, the UK manufacturer of Mounjaro, has said patient safety is its "top priority".
The drug's patient information leaflet "warns that inflamed pancreas (acute pancreatitis) is an uncommon side effect (which may affect up to 1 in 100 people)," the statement continued.
Lily "also advises patients to talk to their doctor or other healthcare professional before using Mounjaro if they have ever had pancreatitis," it added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
20 minutes ago
- The Independent
If Labour cuts my PIP, I lose everything I have worked for
It's been a horrific few weeks – few months – for disabled people, with the never-ending uncertainty around the Labour government's disability benefit cuts making our community scared for our lives. The government claims their welfare reforms are to help support disabled people into work, but they're ignoring the fact that many disabled people can only work because of the benefits they receive – and I'm one of them. I live with a wide range of conditions including lupus, endometriosis, arthritis, migraines and dyspraxia, the toll these have on my body means that my disability mostly manifests through lack of energy and cognitive function. I would never be able to work a full time job or one with a strict schedule, as I can only work for a few hours at a time before I can't look at a screen anymore. I mostly work from bed as that's where I'm most comfortable. However, I've still managed to build a pretty successful career as a writer. With my limited energy and time, I've also helped shape the Taking the PIP campaign, which has brought together more than 130 well-known disabled people to urge the prime minister to stop the cruel cuts to benefits. But the harsh reality is that if these cuts are approved next week, with a second reading vote on the welfare reform bill, I will lose everything I have. I receive £558 a month in PIP. I also receive Universal Credit, the amount of which changes every month because I have to input my earnings, but is roughly around £400 a month. At a time when I only have the energy to work one or two hours a week, it means that I'm not working myself to the bone in order to be able to afford to live and can still afford my bills. Currently, you have to score 8 points to qualify for the daily living component of PIP. But if the eligibility changes come in, you will also have to score at least 4 points in one activity – these involving your ability to cook and clean, socialise and maintain good hygiene. On my last assessment, the highest I scored on all activities was 2. Due to my depression and neurodivergent conditions, I've made myself ill in the past with bad hygiene. I have to be reminded or pushed to keep myself clean. When I'm in deep depressive episodes, I will go days, or sometimes even weeks, without changing my clothes or washing myself. It's unsafe for me to do certain things in the kitchen as I sometimes lack control of my hands. I enjoy cooking, but often cut or burn myself and struggle to use many kitchen utensils. My cognitive and mental health conditions also mean I put housework at the bottom of the list, and prioritise just keeping myself alive. Only this week, I had to deep-clean my house – with the support of friends – after I discovered a fly infestation. But I make allowances so that I can live a good, independent life. I have apps that remind me to clean and eat, I buy pre-sliced food or mostly rely on ready meals. I live in social housing, in an accessible bungalow, so I can move around it safely without fear that I will put myself in danger. I live five minutes from my parents, who are on hand to help with housework. But if Labour's cuts to PIP go through, I won't be able to afford to continue living my lovely little life. I will be forced to find a job that will push me mentally and physically to breaking point. If I lose my PIP, I genuinely can't guarantee I'll still be here in five years time. And I'm far from the only one. Under Labour plans, more than 3.2 million people will see their benefits cut, pushing around 8,000 people into poverty or even absolute poverty, which is defined by the UN as 'a condition characterised by severe deprivation of basic human needs, including food, safe drinking water, sanitation facilities, health, shelter, education and information. It depends not only on income but also on access to services.' More than 280,000 PIP claimants who are already in work would lose their support – and, as a result, could lose their jobs. In return, just 1-3 per cent of those affected will be able to move into work. While many working people will be affected, those who can't work will also be hard hit. Where I agree with the government is that the welfare system does need reform, but only to make it more compassionate and less inhumane. Starmer says the welfare system 'doesn't work for anyone', and that it's 'counterproductive' and 'works against them getting into work'. It is all well and good the government saying they want to support people into work – but when they're also quietly cutting Access to Work entitlement, their actions don't show it. I hear every single day from scared disabled people who have no idea how they'll survive if these cuts go through. The government can claim this is a cost-cutting measure all they want, but the reality is that the very real cost will be that of disabled people's lives. Is that really a debt politicians want on their hands? * Rachel Charlton-Dailey is a journalist and disability rights campaigner who is part of the 'Taking the PIP' campaign
Daily Mail
26 minutes ago
- Daily Mail
Beauty fans are racing to snap up this new Elizabeth Arden SPF with 20% off - plus score free gifts when you shop
Summer is here, and if there's one thing more important than booking in multiple garden BBQs, then it is making sure you've got the right face SPF. Thankfully, Elizabeth Arden has us well and truly covered. Coined 'flawless' by impressed reviewers, the Elizabeth Arden Eight Hour® HydraPlay™ Daily Defense Nourishing Fluid SPF40 is a lightweight formula designed to hydrate and protect the skin for a glowing finish. The best part? You can score 20 per cent off for a limited time. Eight Hour HydraPlay Daily Defense Nourishing Fluid Broad Spectrum SPF 40, 50ml Designed for impressive comfort and protection, the Eight Hour® HydraPlay™ Daily Defense Nourishing Fluid boasts SPF40 protection to keep your skin shielded from UVA/UVB rays, blue light and pollution with no white cast or oily residue. The lightweight and non-sticky formula looks flawless on the skin while remaining fragrance-free and perfect for sensitive skin. MailOnline shoppers can score a huge 20 per cent off this bestselling formula when you purchase two items from the new Hydraplay™ Collection using code PLAY20. £25.60 (save £6.40) Shop That's right, MailOnline shoppers can score a huge 20 per cent off this bestselling formula when you purchase two items from the new Hydraplay™ Collection using code PLAY20, an unmissable saving on cult-favourite skincare. Better still, this exclusive code will entitle you to two free deluxe samples with your purchase of any Hydraplay product, the perfect way to try out new formulas for less. Designed for impressive comfort and protection, the Eight Hour® HydraPlay™ Daily Defense Nourishing Fluid boasts SPF40 protection to keep your skin shielded from UVA/UVB rays, blue light and pollution without any white cast or oily residue. The totally lightweight and non-sticky formula has been designed to look flawless on the skin while remaining fragrance-free and gentle on sensitive skin, ensuring no stinging in sensitive areas - with many users raving about its 'ultra-gentle formula'. 'I love how it gives my skin a healthy, dewy glow without looking oily. You can see in the close-up—my skin looks hydrated, smooth, and radiant,' wrote one impressed five-star reviewer. 'It wears beautifully under makeup and hasn't caused any irritation or breakouts, which is a big plus for my sensitive skin.' This is all thanks to the inclusion of a whole host of skin-loving ingredients that work together to deliver the perfect, glow-giving and deeply hydrating finish that's perfect for everyday wear. These include a Botanical Blend of rice and soybean oil that helps protect against the skin-ageing effects of blue light and pollution, sugar beet extract to strengthen the skin's moisture barrier and antioxidants to soothe and defend against the ageing effects of pollution. And users say it's the ' perfect SPF for summer', raving about its lightweight texture, hydrating formula and 'gorgeous glowy finish' it leaves. Ready to upgrade your sun protection? Snap up this top-rated formula and any other Hydraplay product today and save a whopping 20 per cent using code PLAY20 'I really loved this sunscreen. I've been using it nonstop since it arrived it's almost gone!' wrote one five-star reviewer. 'It has a lightweight texture, leaves no white cast, and feels hydrating without being greasy. Perfect under makeup and gentle on my sensitive skin. A daily essential!' Another added: 'This product is highly recommended. Not only has sunscreen but the hydration it provides is phenomenal and one of the best I have ever used. Definitely a must have!' 'OMG-I haven't used Elizabeth Arden for years,' a third reviewer explained. 'I forgot what great products they have. I've been using the Eight Hour HydraPlay Daily for the past month and am LOVING IT.' 'I use it in the morning in place of my moisturizer and sunscreen. It works great under my makeup and is not sticky nor does it leave a white residue.' Ready to upgrade your sun protection? Snap up this top-rated formula and any other Hydraplay product today and save a whopping 20 per cent using code PLAY20. Elizabeth Arden Hydraplay collection
The Guardian
33 minutes ago
- The Guardian
As an NHS GP, I can now prescribe weight-loss jabs – but a quick fix for obesity is not what we need
A medicine that takes away your appetite by making you feel full and a bit nauseous doesn't sound very attractive, but it is a price many people are ready to pay for the chance to lose weight. Although widely available privately, until this week only doctors in specialist clinics were allowed to prescribe tirzepatide (Mounjaro) to treat obesity on the NHS and it was almost impossible for GPs to get their patients into these clinics. People up and down England will no doubt rejoice at the news that their own doctor can now prescribe it. Any celebrations may be premature, as the criteria for prescription in the first phase of the rollout are so tightly drawn that few patients will qualify. You need a body mass index (BMI) of more than 40, which corresponds to a weight of 102kg (16st) for a woman of average height or 123kg (more than 19st) for a man. (The BMI criterion is slightly lower if you come from a high-risk group.) To be eligible, patients need to be not just at risk of complications from their obesity, but already suffering from them. They must have existing diagnoses of four out of five specific conditions: type 2 diabetes, high blood pressure, abnormal levels of fats in the blood (dyslipidaemia), obstructive sleep apnoea and damage to blood vessels. Individually, all of these conditions are fairly common, and they are more likely if you are obese. However, in our GP practice of 12,500 patients, we have identified only two who meet these criteria. Anticipating a rush of inquiries, we have asked our reception staff to tell patients that we will contact them if they qualify. In the second phase of the rollout, expected next summer, the BMI threshold will be lowered, although as the list of conditions will stay the same, it seems unlikely many more of my patients will qualify. I have some patients who are really stuck with very severe obesity, with a BMI of more than 50, who I think would benefit from this medication, yet I cannot prescribe it as they do not have the specified diagnoses. One of the reasons for the slow pace of the rollout mandated by NHS England is probably a fear of overwhelming GP services. Six hours of training is advised before we start prescribing, and patients should be seen monthly and monitored for adverse effects as the dose is increased, and then every six months. As the criteria relax, and the number of eligible patients expands, this will add up to a lot of extra appointments. Along with the injections, patients should also have 'wraparound care', which will provide diet and exercise advice. We are waiting to hear from our integrated care board about exactly how this will be provided to our patients, but the dietary advice is important. Many people who are obese are nevertheless malnourished as the food they eat is often high in fat and sugar and low in essential nutrients. If, in response to appetite suppression, they eat very much less of the same low-quality food, they may run into significant problems with lack of protein, vitamins and minerals. Dehydration may also be a problem as thirst is reduced as well as hunger. Rapid weight reduction causes loss of bone and muscle mass as well as fat, so exercise is needed to prevent frailty. Tirzepatide is not cheap: at the maximum dose, it costs £122 a patient a month, or £1,464 a year. This could be considered a bargain if you compare it with the cost of treating obesity-related conditions, and we should factor in the improvements in quality of life that achieving a healthy weight will bring. However, there are big questions to answer around how long people should use weight-loss drugs for, and what happens when they stop. Rebound weight gain is almost universal after a period of dieting but it appears to be even more rapid after taking drugs such as tirzepatide; one study has found that patients can expect to return to their original weight within under two years of stopping. This feels inevitable, as much of dieting is learning to change your response to your body's signals of hunger; if you've been taking a drug that abolishes those signals, then when you stop and your appetite returns, you are likely to respond exactly as you did in the past. At a population level, I worry that by concentrating on this technical, pharmaceutical fix to our obesity problem, we are heading down the wrong path. More than a quarter of the adult population in England is obese, and medicating them all in perpetuity surely cannot be the answer. If the government is serious about its much-heralded shift from treatment to prevention, we need bolder and more imaginative plans to tackle obesity. We need restrictions on the availability of calorie-dense, nutritionally poor, fast food. Taxing sugar and fat would be one way of altering the nation's diet, and we should also look at the quality of school meals. Beyond food regulation, we need to buy back school playing fields, offer opportunities to exercise for free, and encourage active transport by making pavements pleasant and cycle routes safe. The current obesity crisis arises from a complex mix of social and commercial determinants of health and these are not problems that can be fixed with a simple injection. Helen Salisbury is a GP in Oxford
